Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Altria Group
MO
|
+$428M |
| 2 |
BlackRock US Equity Factor Rotation ETF
DYNF
|
+$232M |
| 3 |
Grayscale Bitcoin Trust
GBTC
|
+$208M |
| 4 |
Morgan Stanley Direct Lending Fund
MSDL
|
+$201M |
| 5 |
Infosys
INFY
|
+$134M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$50.9B |
| 2 |
Apple
AAPL
|
+$38.9B |
| 3 |
Amazon
AMZN
|
+$26B |
| 4 |
NVIDIA
NVDA
|
+$23.3B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$17B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.37% |
| 2 | Financials | 10.81% |
| 3 | Healthcare | 9.76% |
| 4 | Consumer Discretionary | 9.08% |
| 5 | Industrials | 6.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FSP
3951
Franklin Street Properties
FSP
$46.8M
| $4.37M | ﹤0.01% |
1,923,797
-1,784,509
| -48% | -$4.26M |
|
3952
Genius Sports
GENI
$2.11B
| $4.33M | ﹤0.01% |
757,600
-704,728
| -48% | -$4.53M |
|
3953
VanEck Mortgage REIT Income ETF
MORT
$385M
| $4.32M | ﹤0.01% |
369,470
-610,834
| -62% | -$6.91M |
|
|
TBLD
3954
Thornburg Income Builder Opportunities Trust
TBLD
$716M
| $4.3M | ﹤0.01% |
266,207
-268,775
| -50% | -$4.24M |
|
3955
Lightspeed Commerce
LSPD
$1.35B
| $4.3M | ﹤0.01% |
306,027
-857,397
| -74% | -$13.6M |
|
3956
Nuvation Bio
NUVB
$2.32B
| $4.3M | ﹤0.01% |
1,181,601
-423,487
| -26% | -$813K |
|
3957
Nuveen Core Equity Alpha Fund
JCE
$288M
| $4.3M | ﹤0.01% |
305,665
-245,023
| -44% | -$3.33M |
|
3958
Trinity Capital Inc.
TRIN
$1.71B
| $4.28M | ﹤0.01% |
291,731
-56,211
| -16% | -$811K |
|
3959
QuickLogic
QUIK
$257M
| $4.28M | ﹤0.01% |
267,102
+126,146
| +89% | +$1.82M |
|
3960
Invesco MSCI Sustainable Future ETF
ERTH
$138M
| $4.27M | ﹤0.01% |
101,016
-105,612
| -51% | -$4.47M |
|
3961
VanEck Video Gaming and eSports ETF
ESPO
$258M
| $4.27M | ﹤0.01% |
68,244
-117,368
| -63% | -$7.03M |
|
3962
Invesco Quality Municipal Securities
IQI
$534M
| $4.26M | ﹤0.01% |
440,571
-464,741
| -51% | -$4.44M |
|
3963
FuelCell Energy
FCEL
$1.63B
| $4.26M | ﹤0.01% |
119,406
-64,522
| -35% | -$2.38M |
|
3964
Tootsie Roll Industries
TR
$2.98B
| $4.26M | ﹤0.01% |
141,112
-100,370
| -42% | -$3.04M |
|
|
GSWO
3965
Goldman Sachs ActiveBeta World Equity ETF
GSWO
$1.78B
| $4.25M | ﹤0.01% |
90,644
-176,508
| -66% | -$7.98M |
|
3966
Indivior Pharmaceuticals
INDV
$4.58B
| $4.25M | ﹤0.01% |
198,251
+186,425
| +1,576% | +$3.5M |
|
|
OLPX
3967
DELISTED
Olaplex Holdings
OLPX
| $4.24M | ﹤0.01% |
2,209,520
-1,439,830
| -39% | -$3M |
|
3968
Zai Lab
ZLAB
$2.62B
| $4.24M | ﹤0.01% |
264,709
-317,163
| -55% | -$6.68M |
|
3969
Vishay Precision Group
VPG
$914M
| $4.22M | ﹤0.01% |
119,464
-178,740
| -60% | -$5.92M |
|
3970
PureCycle Technologies
PCT
$1.45B
| $4.21M | ﹤0.01% |
677,500
-1,425,910
| -68% | -$6.64M |
|
|
MCBC
3971
DELISTED
Macatawa Bank Corp
MCBC
| $4.21M | ﹤0.01% |
430,435
-431,713
| -50% | -$4.42M |
|
3972
State Street SPDR S&P Emerging Asia Pacific ETF
GMF
$438M
| $4.21M | ﹤0.01% |
40,621
-40,319
| -50% | -$4.07M |
|
3973
Westlake Chemical Partners
WLKP
$763M
| $4.21M | ﹤0.01% |
189,517
-208,979
| -52% | -$4.69M |
|
3974
Lifecore Biomedical
LFCR
$190M
| $4.2M | ﹤0.01% |
791,807
-785,597
| -50% | -$5.62M |
|
3975
C4 Therapeutics
CCCC
$412M
| $4.2M | ﹤0.01% |
514,183
+103,501
| +25% | +$802K |
|
Similar funds
Morgan Stanley's Q1 2024 Portfolio in Review
As of Q1 2024, Morgan Stanley held 8,154 positions worth $1.25T, down 45% from $2.27T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Morgan Stanley withdrew a net $1.16T in Q1 2024, closing 332 positions and reducing 6,745 holdings. Its most notable exit was Mirati Therapeutics, Inc. Common Stock, an estimated $725M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Morgan Stanley opened a new position in Grayscale Bitcoin Trust worth $270M.
- Morgan Stanley's largest Q1 2024 buy was Grayscale Bitcoin Trust: 4,729,259 shares worth $270M.
- Morgan Stanley added most to Altria Group in Q1 2024, an estimated $428M increase.
- Morgan Stanley's biggest Q1 2024 reduction was Microsoft, cutting an estimated $50.9B.
- Morgan Stanley fully exited Mirati Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $725M.
- Morgan Stanley's ten largest holdings make up 19% of its $1.25T portfolio in Q1 2024.
- Morgan Stanley opened 333 new positions and closed 332 in Q1 2024.
- Morgan Stanley's portfolio value fell 45% quarter-over-quarter to $1.25T.
Based on Morgan Stanley's 13F filing for Q1 2024, filed 15 May 2024.